Effect of fluoroscopy utilization monitoring on fluoroscopy times during ERCP

A. A. Alkhatib, M. E. Harrison, Rahul Pannala, D. O'Faigel

Research output: Contribution to journalArticle

Abstract

Aim. The aim of the present study was to find whether informing endoscopists that their FT is being tracked would result in decreasing their overall fluoroscopy utilization as measured by FT. Methods. We reviewed the medical charts of patients underwent ERCP from April 2011 to May 2012. On December 15, 2011, the endoscopists were informed about their mean FT during ERCP, were encouraged to decrease FT and were informed their FT would be monitored. We compared the mean FT of the endoscopists individually and as a group before and after December 15, 2011. Results. The study included 293 patients and 3 endoscopists. Before informing the endoscopists that their FT was being tracked, utilization of fluoroscopy was significantly variable among endoscopists. The mean FT for all endoscopists was 9.04 minutes and for each endoscopist was 6.06, 11.43, and 7.67 minutes, respectively (P<0.02). After informing the endoscopists that their FT will be followed, there was a trend toward a decrease in FT among the group (9.04 vs. 7.4 minutes, P=0.06). However, the changes in FT among endoscopists individually were variable. The FT for first, second and third endoscopists changed from 6.06min to 3.39 min, p<0.02, 11,43 min to 8.8 min, P=0.14 and 7.67 to 11.47 minutes, P=0.06, respectively. Conclusion. Fluoroscopic utilization during ERCP among endoscopists is variable. Endoscopists' knowledge that their FT during ERCP is being tracked leads to variable resuits among endoscopists. Nonetheless, overall it leads to a trend in reducing fluoroscopy utilization.

Original languageEnglish (US)
Pages (from-to)211-215
Number of pages5
JournalMinerva Gastroenterologica e Dietologica
Volume59
Issue number2
StatePublished - Jun 2013

Fingerprint

Endoscopic Retrograde Cholangiopancreatography
Fluoroscopy

Keywords

  • Cholangiopancreatography, endoscopic retrograde
  • Endoscopy
  • Fluoroscopy

ASJC Scopus subject areas

  • Gastroenterology
  • Internal Medicine
  • Nutrition and Dietetics
  • Endocrinology, Diabetes and Metabolism

Cite this

Effect of fluoroscopy utilization monitoring on fluoroscopy times during ERCP. / Alkhatib, A. A.; Harrison, M. E.; Pannala, Rahul; O'Faigel, D.

In: Minerva Gastroenterologica e Dietologica, Vol. 59, No. 2, 06.2013, p. 211-215.

Research output: Contribution to journalArticle

Alkhatib, A. A. ; Harrison, M. E. ; Pannala, Rahul ; O'Faigel, D. / Effect of fluoroscopy utilization monitoring on fluoroscopy times during ERCP. In: Minerva Gastroenterologica e Dietologica. 2013 ; Vol. 59, No. 2. pp. 211-215.
@article{82a416e88a734291a73805d4f1ed132a,
title = "Effect of fluoroscopy utilization monitoring on fluoroscopy times during ERCP",
abstract = "Aim. The aim of the present study was to find whether informing endoscopists that their FT is being tracked would result in decreasing their overall fluoroscopy utilization as measured by FT. Methods. We reviewed the medical charts of patients underwent ERCP from April 2011 to May 2012. On December 15, 2011, the endoscopists were informed about their mean FT during ERCP, were encouraged to decrease FT and were informed their FT would be monitored. We compared the mean FT of the endoscopists individually and as a group before and after December 15, 2011. Results. The study included 293 patients and 3 endoscopists. Before informing the endoscopists that their FT was being tracked, utilization of fluoroscopy was significantly variable among endoscopists. The mean FT for all endoscopists was 9.04 minutes and for each endoscopist was 6.06, 11.43, and 7.67 minutes, respectively (P<0.02). After informing the endoscopists that their FT will be followed, there was a trend toward a decrease in FT among the group (9.04 vs. 7.4 minutes, P=0.06). However, the changes in FT among endoscopists individually were variable. The FT for first, second and third endoscopists changed from 6.06min to 3.39 min, p<0.02, 11,43 min to 8.8 min, P=0.14 and 7.67 to 11.47 minutes, P=0.06, respectively. Conclusion. Fluoroscopic utilization during ERCP among endoscopists is variable. Endoscopists' knowledge that their FT during ERCP is being tracked leads to variable resuits among endoscopists. Nonetheless, overall it leads to a trend in reducing fluoroscopy utilization.",
keywords = "Cholangiopancreatography, endoscopic retrograde, Endoscopy, Fluoroscopy",
author = "Alkhatib, {A. A.} and Harrison, {M. E.} and Rahul Pannala and D. O'Faigel",
year = "2013",
month = "6",
language = "English (US)",
volume = "59",
pages = "211--215",
journal = "Minerva Gastroenterologica",
issn = "0026-4776",
publisher = "Edizioni Minerva Medica S.p.A.",
number = "2",

}

TY - JOUR

T1 - Effect of fluoroscopy utilization monitoring on fluoroscopy times during ERCP

AU - Alkhatib, A. A.

AU - Harrison, M. E.

AU - Pannala, Rahul

AU - O'Faigel, D.

PY - 2013/6

Y1 - 2013/6

N2 - Aim. The aim of the present study was to find whether informing endoscopists that their FT is being tracked would result in decreasing their overall fluoroscopy utilization as measured by FT. Methods. We reviewed the medical charts of patients underwent ERCP from April 2011 to May 2012. On December 15, 2011, the endoscopists were informed about their mean FT during ERCP, were encouraged to decrease FT and were informed their FT would be monitored. We compared the mean FT of the endoscopists individually and as a group before and after December 15, 2011. Results. The study included 293 patients and 3 endoscopists. Before informing the endoscopists that their FT was being tracked, utilization of fluoroscopy was significantly variable among endoscopists. The mean FT for all endoscopists was 9.04 minutes and for each endoscopist was 6.06, 11.43, and 7.67 minutes, respectively (P<0.02). After informing the endoscopists that their FT will be followed, there was a trend toward a decrease in FT among the group (9.04 vs. 7.4 minutes, P=0.06). However, the changes in FT among endoscopists individually were variable. The FT for first, second and third endoscopists changed from 6.06min to 3.39 min, p<0.02, 11,43 min to 8.8 min, P=0.14 and 7.67 to 11.47 minutes, P=0.06, respectively. Conclusion. Fluoroscopic utilization during ERCP among endoscopists is variable. Endoscopists' knowledge that their FT during ERCP is being tracked leads to variable resuits among endoscopists. Nonetheless, overall it leads to a trend in reducing fluoroscopy utilization.

AB - Aim. The aim of the present study was to find whether informing endoscopists that their FT is being tracked would result in decreasing their overall fluoroscopy utilization as measured by FT. Methods. We reviewed the medical charts of patients underwent ERCP from April 2011 to May 2012. On December 15, 2011, the endoscopists were informed about their mean FT during ERCP, were encouraged to decrease FT and were informed their FT would be monitored. We compared the mean FT of the endoscopists individually and as a group before and after December 15, 2011. Results. The study included 293 patients and 3 endoscopists. Before informing the endoscopists that their FT was being tracked, utilization of fluoroscopy was significantly variable among endoscopists. The mean FT for all endoscopists was 9.04 minutes and for each endoscopist was 6.06, 11.43, and 7.67 minutes, respectively (P<0.02). After informing the endoscopists that their FT will be followed, there was a trend toward a decrease in FT among the group (9.04 vs. 7.4 minutes, P=0.06). However, the changes in FT among endoscopists individually were variable. The FT for first, second and third endoscopists changed from 6.06min to 3.39 min, p<0.02, 11,43 min to 8.8 min, P=0.14 and 7.67 to 11.47 minutes, P=0.06, respectively. Conclusion. Fluoroscopic utilization during ERCP among endoscopists is variable. Endoscopists' knowledge that their FT during ERCP is being tracked leads to variable resuits among endoscopists. Nonetheless, overall it leads to a trend in reducing fluoroscopy utilization.

KW - Cholangiopancreatography, endoscopic retrograde

KW - Endoscopy

KW - Fluoroscopy

UR - http://www.scopus.com/inward/record.url?scp=84884689836&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84884689836&partnerID=8YFLogxK

M3 - Article

C2 - 23831911

AN - SCOPUS:84884689836

VL - 59

SP - 211

EP - 215

JO - Minerva Gastroenterologica

JF - Minerva Gastroenterologica

SN - 0026-4776

IS - 2

ER -